Related Experiment Video
Updated: May 21, 2026

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes
Published on: March 12, 2013
Long QT2 mutation on the Kv11.1 ion channel inhibits current activity by ablating a protein kinase Cα consensus site
Alexander J Donovan1, Katherine Lansu, Jason G Williams
1Departments of Molecular Pharmacology and Therapeutics, Loyola University, Chicago, Illinois, USA.
Abstract:
Mutations that inhibit Kv11.1 ion channel activity contribute to abnormalities of cardiac repolarization that can lead to long QT2 (LQT2) cardiac arrhythmias and sudden death. However, for most of these mutations, nothing is known about the molecular mechanism linking Kv11.1 malfunction to cardiac death. We have previously demonstrated that disease-related mutations that create consensus sites for kinases on ion channels can dramatically change ion channel activity. Here, we show that a LQT2-associated mutation can inhibit Kv11.1 ion channel activity by perturbing a consensus site for the Ser/Thr protein kinase C α (PKCα). We first reveal by mass spectrometry analysis that Ser890 of the Kv11.1 ion channel is phosphorylated. Then, we demonstrate by a phospho-detection immunoassay combined with genetic manipulation that PKCα phosphorylates Ser890. Furthermore, we show that Ser890 phosphorylation is associated with an increase in Kv11.1 membrane density with alteration of recovery from inactivation. In addition, a newly discovered and as yet uncharacterized LQT2-associated nonsynonymous single nucleotide polymorphism 2660 G→A within the human ether-á-go-go-related gene 1 coding sequence, which replaces arginine 887 with a histidine residue (R887H), strongly inhibits PKCα-dependent phosphorylation of residue Ser890 on Kv11.1, and ultimately inhibits surface expression and current density. Taken together, our data provide a functional link between this channel mutation and LQT2.
Insights
Mutations in the Kv11.1 ion channel cause long QT2 (LQT2) syndrome. This study reveals how a specific LQT2 mutation disrupts Kv11.1 channel function by affecting its phosphorylation by protein kinase C alpha (PKCα).
Area of Science:
- Molecular biology
- Cardiology
- Ion channel physiology
Background:
- Mutations in the Kv11.1 ion channel are linked to long QT2 (LQT2) syndrome, a condition causing cardiac arrhythmias and sudden death.
- The precise molecular mechanisms underlying Kv11.1 malfunction in LQT2 remain largely unknown.
- Disease-associated mutations can alter ion channel activity by affecting kinase consensus sites.
Purpose of the Study:
- To investigate the molecular mechanism by which a LQT2-associated mutation affects Kv11.1 ion channel activity.
- To determine the role of protein kinase C alpha (PKCα) and Ser890 phosphorylation in Kv11.1 channel function and LQT2 pathogenesis.
Main Methods:
- Mass spectrometry to identify phosphorylation sites on Kv11.1.
- Phospho-detection immunoassay and genetic manipulation to confirm PKCα phosphorylation of Ser890.
- Electrophysiological studies and surface expression analysis to assess channel function.
Main Results:
- Ser890 of the Kv11.1 ion channel is phosphorylated by PKCα.
- PKCα-dependent phosphorylation of Ser890 influences Kv11.1 membrane density and recovery from inactivation.
- A novel LQT2 mutation (R887H) inhibits PKCα-dependent phosphorylation of Ser890, reducing Kv11.1 surface expression and current density.
Conclusions:
- The study provides a molecular link between a Kv11.1 mutation and LQT2 by demonstrating the role of PKCα-mediated phosphorylation of Ser890.
- Perturbation of this phosphorylation site by mutations significantly impairs Kv11.1 channel function, contributing to LQT2 pathophysiology.
More Related Videos
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
12:48Measuring Cation Transport by Na,K- and H,K-ATPase in Xenopus Oocytes by Atomic Absorption Spectrophotometry: An Alternative to Radioisotope Assays
Published on: February 19, 2013
Related Concept Videos
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Ion Channels
Ion channels are specialized integral membrane proteins on the plasma membrane that allow specific...